Edwards Lifesciences Corporation (EW)

Edwards Lifesciences Revenue

Edwards Lifesciences had revenue of $1.35B in the quarter ending September 30, 2024, with 8.93% growth. This brings the company's revenue in the last twelve months to $6.31B, up 24.02% year-over-year. In the year 2023, Edwards Lifesciences had annual revenue of $6.00B with 11.56% growth.

• Revenue (ttm): $6.31B
• Revenue Growth: +24.02%
• P/S Ratio: 7.13
• Revenue / Employee: $318,934
• Employees: 19,800
• Market Cap: 44.12B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	6.00B	622.40M	11.56%
Dec 31, 2022	5.38B	149.90M	2.86%
Dec 31, 2021	5.23B	846.20M	19.29%
Dec 31, 2020	4.39B	38.30M	0.88%
Dec 31, 2019	4.35B	625.20M	16.79%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.